These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29689302)

  • 1. Cyclodextrins as excipients in tablet formulations.
    Conceição J; Adeoye O; Cabral-Marques HM; Lobo JMS
    Drug Discov Today; 2018 Jun; 23(6):1274-1284. PubMed ID: 29689302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxypropyl-β-Cyclodextrin and β-Cyclodextrin as Tablet Fillers for Direct Compression.
    Conceição J; Adeoye O; Cabral-Marques HM; Sousa Lobo JM
    AAPS PharmSciTech; 2018 Aug; 19(6):2710-2718. PubMed ID: 29978292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclodextrins in pharmaceutical formulations II: solubilization, binding constant, and complexation efficiency.
    Jambhekar SS; Breen P
    Drug Discov Today; 2016 Feb; 21(2):363-8. PubMed ID: 26687191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes.
    Loftsson T; Brewster ME
    J Pharm Pharmacol; 2011 Sep; 63(9):1119-35. PubMed ID: 21827484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclodextrins as functional excipients: methods to enhance complexation efficiency.
    Loftsson T; Brewster ME
    J Pharm Sci; 2012 Sep; 101(9):3019-32. PubMed ID: 22334484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclodextrins--enabling excipients: their present and future use in pharmaceuticals.
    Thompson DO
    Crit Rev Ther Drug Carrier Syst; 1997; 14(1):1-104. PubMed ID: 9043816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of the bitter taste of drugs by complexation with cyclodextrins: applications, evaluations and mechanisms.
    Arima H; Higashi T; Motoyama K
    Ther Deliv; 2012 May; 3(5):633-44. PubMed ID: 22834407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of various processes for simultaneous complexation and granulation to incorporate drug-cyclodextrin complexes into solid dosage forms.
    Gyanani V; Siddalingappa B; Betageri GV
    Drug Dev Ind Pharm; 2015; 41(11):1856-63. PubMed ID: 25754112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique structure and property of cyclodextrins and their application in transdermal drug delivery.
    Hu J; Tao Z; Cao S
    Methods Find Exp Clin Pharmacol; 2009 Sep; 31(7):449-56. PubMed ID: 19907720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclodextrin polymer, a new tablet disintegrating agent.
    Fenyvest E; Antal B; Zsadon B; Szejtli J
    Pharmazie; 1984 Jul; 39(7):473-5. PubMed ID: 6494226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-cyclodextrin as a direct compression excipient compared to conventional ones.
    Saleh SI
    J Pharm Belg; 1993; 48(5):371-7. PubMed ID: 8120790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical applications of cyclodextrins: basic science and product development.
    Loftsson T; Brewster ME
    J Pharm Pharmacol; 2010 Nov; 62(11):1607-21. PubMed ID: 21039545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclodextrins: more than pharmaceutical excipients.
    Otero-Espinar FJ; Luzardo-Alvarez A; Blanco-Méndez J
    Mini Rev Med Chem; 2010 Jul; 10(8):715-25. PubMed ID: 20482501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclodextrins in drug delivery.
    Loftsson T; Jarho P; Másson M; Järvinen T
    Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New multifunctional pharmaceutical excipient in tablet formulation based on citric acid-cyclodextrin polymer.
    Garcia-Fernandez MJ; Tabary N; Chai F; Cazaux F; Blanchemain N; Flament MP; Martel B
    Int J Pharm; 2016 Sep; 511(2):913-20. PubMed ID: 27473278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of the SeDeM Diagram expert system to determine the suitability of diluents-disintegrants for direct compression and their use in formulation of ODT.
    Aguilar-Díaz JE; García-Montoya E; Pérez-Lozano P; Suñe-Negre JM; Miñarro M; Ticó JR
    Eur J Pharm Biopharm; 2009 Nov; 73(3):414-23. PubMed ID: 19602435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cyclodextrins on the chemical stability of drugs.
    Popielec A; Loftsson T
    Int J Pharm; 2017 Oct; 531(2):532-542. PubMed ID: 28596139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclodextrins in pharmaceutical formulations I: structure and physicochemical properties, formation of complexes, and types of complex.
    Jambhekar SS; Breen P
    Drug Discov Today; 2016 Feb; 21(2):356-62. PubMed ID: 26686054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of stability and skin permeation by sucrose stearate and cyclodextrins in progesterone nanoemulsions.
    Klang V; Matsko N; Zimmermann AM; Vojnikovic E; Valenta C
    Int J Pharm; 2010 Jun; 393(1-2):152-60. PubMed ID: 20434531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cyclodextrins on drug delivery through biological membranes.
    Loftsson T; Vogensen SB; Brewster ME; Konrádsdóttir F
    J Pharm Sci; 2007 Oct; 96(10):2532-46. PubMed ID: 17630644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.